InsiderClue
Insiders · Profile

Levy Adam Scott

CFO and Secretary at Mineralys Therapeutics · Chief Business Officer at Viridian Therapeutics, Inc.\DE. Filing since 22 Jun 2017. CIK 0001693134

MLYS Mineralys Therapeutics, Inc. CFO and Secretary · 13 trades VRDN Viridian Therapeutics, Inc.\DE Chief Business Officer · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
MLYS Mineralys Therapeutics, Inc.
12 Jan 2026
CFO and Secretary
Sold on a plan
10,758
$345.72K
55.5%
MLYS Mineralys Therapeutics, Inc.
11 Nov 2025
CFO and Secretary
Sold at will
119,524
$5.36M
86.0%
MLYS Mineralys Therapeutics, Inc.
13 Oct 2025
CFO and Secretary
Sold on a plan
10,758
$451.98K
8.4%
MLYS Mineralys Therapeutics, Inc.
30 Jul 2025
CFO and Secretary
Sold at will
59,925
$884.37K
31.1%
MLYS Mineralys Therapeutics, Inc.
29 Jul 2025
CFO and Secretary
Sold at will
807
$11.30K
0.4%
MLYS Mineralys Therapeutics, Inc.
28 Jul 2025
CFO and Secretary
Sold at will
12,946
$181.80K
6.3%
MLYS Mineralys Therapeutics, Inc.
11 Jul 2025
CFO and Secretary
Sold on a plan
10,758
$155.45K
4.9%
MLYS Mineralys Therapeutics, Inc.
11 Apr 2025
CFO and Secretary
Sold on a plan
10,757
$129.68K
4.8%
MLYS Mineralys Therapeutics, Inc.
13 Jan 2025
CFO and Secretary
Sold on a plan
10,757
$97.86K
4.5%
MLYS Mineralys Therapeutics, Inc.
11 Oct 2024
CFO and Secretary
Sold on a plan
10,757
$146.00K
4.3%
MLYS Mineralys Therapeutics, Inc.
11 Jul 2024
CFO and Secretary
Sold on a plan
10,757
$141.39K
4.2%
MLYS Mineralys Therapeutics, Inc.
11 Jun 2024
CFO and Secretary
Sold on a plan
96,815
$1.25M
27.5%
MLYS Mineralys Therapeutics, Inc.
14 Feb 2023
CFO, Chief Bus. Off. and Secy.
Bought
6,250
$100.00K
1.8%
VRDN Viridian Therapeutics, Inc.\DE
13 Feb 2018
Chief Business Officer
Bought
9,090
$50.00K
627%
VRDN Viridian Therapeutics, Inc.\DE
22 Jun 2017
Chief Business Officer
Bought
200
$1.51K
opened
15 decisions on file.